RESEARCH NOTE
·
Immutep Ltd (IMM)
Should we buy the stock of this biotechnology company?
Healthcare
Daily
ASX
This report is available to subscribers
The full research note on Immutep Ltd — our view, the levels we are working to and the reasoning behind them — is part of a Kapitales subscription.